Guangdong Taienkang Pharmaceutical Co. Ltd (301263) — Capital Reinvestment Ratio
Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has a Capital Reinvestment Ratio of 0.77x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥89.33 Million) in capital expenditures (CN¥68.55 Million). See Guangdong Taienkang Pharmaceutical Co. L free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guangdong Taienkang Pharmaceutical Co. Ltd Capital Reinvestment Ratio (2019–2024)
This chart tracks Guangdong Taienkang Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2024)
Year-by-year Capital Reinvestment Ratio for Guangdong Taienkang Pharmaceutical Co. Ltd from 2019 to 2024. For live market cap and broader valuation context, see market value of Guangdong Taienkang Pharmaceutical Co. L.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.77x | CN¥89.33 Million | CN¥68.55 Million | ▼ -64.1% |
| 2023 | 2.14x | CN¥93.53 Million | CN¥200.01 Million | ▲ +254.1% |
| 2022 | 0.60x | CN¥148.81 Million | CN¥89.88 Million | ▲ +62.4% |
| 2021 | 0.37x | CN¥120.02 Million | CN¥44.65 Million | ▼ -49.9% |
| 2020 | 0.74x | CN¥125.53 Million | CN¥93.12 Million | ▲ +533.5% |
| 2019 | 0.12x | CN¥75.44 Million | CN¥8.83 Million | — |